Back to Report Store Home

Blood Pressure Disorders Drug Development Pipeline Review, 2018

  • Published: Aug-2018
  • Report Code: GBIHC043IDB
  • Report Format: pdf

Description

List of Figures

Figure 1: Number of Products under Development for Hypertension

Figure 2: Number of Products under Development by Companies Hypertension

Figure 3: Number of Products under Development by Universities/Institutes Hypertension

Figure 4: Number of Products under Development for Hypotension

Figure 5: Number of Products under Development by Companies Hypotension

Figure 6: Number of Products under Development for Pulmonary Arterial Hypertension

Figure 7: Number of Products under Development by Companies Pulmonary Arterial Hypertension

Figure 8: Number of Products under Development by Universities/Institutes Pulmonary Arterial Hypertension

Figure 9: Number of Products by Top 10 Targets Hypertension

Figure 10: Number of Products by Stage and Top 10 Targets Hypertension

Figure 11: Number of Products by Top 10 Mechanism of Actions Hypertension

Figure 12: Number of Products by Stage and Top 10 Mechanism of Actions Hypertension

Figure 13: Number of Products by Top 10 Routes of Administration Hypertension

Figure 14: Number of Products by Stage and Top 10 Routes of Administration Hypertension

Figure 15: Number of Products by Top 10 Molecule Types Hypertension

Figure 16: Number of Products by Stage and Top 10 Molecule Types Hypertension

Figure 17: Number of Products by Targets Hypotension

Figure 18: Number of Products by Stage and Targets Hypotension

Figure 19: Number of Products by Mechanism of Actions Hypotension

Figure 20: Number of Products by Stage and Mechanism of Actions Hypotension

Figure 21: Number of Products by Routes of Administration Hypotension

Figure 22: Number of Products by Stage and Routes of Administration Hypotension

Figure 23: Number of Products by Molecule Types Hypotension

Figure 24: Number of Products by Stage and Molecule Types Hypotension

Figure 25: Number of Products by Top 10 Targets Pulmonary Arterial Hypertension

Figure 26: Number of Products by Stage and Top 10 Targets Pulmonary Arterial Hypertension

Figure 27: Number of Products by Top 10 Mechanism of Actions Pulmonary Arterial Hypertension

Figure 28: Number of Products by Stage and Top 10 Mechanism of Actions Pulmonary Arterial Hypertension

Figure 29: Number of Products by Routes of Administration Pulmonary Arterial Hypertension

Figure 30: Number of Products by Stage and Routes of Administration Pulmonary Arterial Hypertension

Figure 31: Number of Products by Top 10 Molecule Types Pulmonary Arterial Hypertension

Figure 32: Number of Products by Stage and Top 10 Molecule Types Pulmonary Arterial Hypertension

 
      captcha refresh

I have read and accept terms and conditions and privacy policy

Cancel
License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$3995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$7990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$11985
Email to a colleague Request Sample Pages Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards